These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18427209)

  • 1. Emergence of X4 usage among HIV-1 subtype C: evidence for an evolving epidemic in South Africa.
    Connell BJ; Michler K; Capovilla A; Venter WD; Stevens WS; Papathanasopoulos MA
    AIDS; 2008 Apr; 22(7):896-9. PubMed ID: 18427209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypic and phenotypic analysis of the env gene from South African HIV-1 subtype B and C isolates.
    Treurnicht FK; Smith TL; Engelbrecht S; Claassen M; Robson BA; Zeier M; van Rensburg EJ
    J Med Virol; 2002 Oct; 68(2):141-6. PubMed ID: 12210400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic characteristics of the V3 region associated with CXCR4 usage in HIV-1 subtype C isolates.
    Coetzer M; Cilliers T; Ping LH; Swanstrom R; Morris L
    Virology; 2006 Dec 5-20; 356(1-2):95-105. PubMed ID: 16942785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biological characteristics of HIV-1 isolates circulating in China are linked to its env V3 loop sequence variability].
    Hei FX; Hong KX; Song YH; Tang HL; Peng H; Xu JQ; Xing H; Shao YM
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1968-72. PubMed ID: 15730807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replicative fitness of CCR5-using and CXCR4-using human immunodeficiency virus type 1 biological clones.
    Ariën KK; Gali Y; El-Abdellati A; Heyndrickx L; Janssens W; Vanham G
    Virology; 2006 Mar; 347(1):65-74. PubMed ID: 16386774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-receptor usage was more predictive than NSI/SI phenotype for HIV replication in macrophages: is NSI/SI phenotyping sufficient?
    Lathey JL; Brambilla D; Goodenow MM; Nokta M; Rasheed S; Siwak EB; Bremer JW; Huang DD; Yi Y; Reichelderfer PS; Collman RG
    J Leukoc Biol; 2000 Sep; 68(3):324-30. PubMed ID: 10985247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism.
    Raymond S; Delobel P; Mavigner M; Cazabat M; Souyris C; Sandres-Sauné K; Cuzin L; Marchou B; Massip P; Izopet J
    AIDS; 2008 Sep; 22(14):F11-6. PubMed ID: 18753930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients.
    Björndal A; Sönnerborg A; Tscherning C; Albert J; Fenyö EM
    AIDS Res Hum Retroviruses; 1999 May; 15(7):647-53. PubMed ID: 10331443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C-infected children with slow and rapid disease progression.
    Choge I; Cilliers T; Walker P; Taylor N; Phoswa M; Meyers T; Viljoen J; Violari A; Gray G; Moore PL; Papathanosopoulos M; Morris L
    AIDS Res Hum Retroviruses; 2006 May; 22(5):458-65. PubMed ID: 16706624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
    AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4.
    Michler K; Connell BJ; Venter WD; Stevens WS; Capovilla A; Papathanasopoulos MA
    AIDS Res Hum Retroviruses; 2008 May; 24(5):743-51. PubMed ID: 18507530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switch.
    Mild M; Esbjörnsson J; Fenyö EM; Medstrand P
    J Virol; 2007 Apr; 81(7):3369-76. PubMed ID: 17251288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current V3 genotyping algorithms are inadequate for predicting X4 co-receptor usage in clinical isolates.
    Low AJ; Dong W; Chan D; Sing T; Swanstrom R; Jensen M; Pillai S; Good B; Harrigan PR
    AIDS; 2007 Sep; 21(14):F17-24. PubMed ID: 17721088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High specificity of V3 serotyping among human immunodeficiency virus type-1 subtype C infected patients with varying disease status and viral phenotype.
    Walker PR; Cilliers T; Choge IA; Taylor N; Cohen SS; Morris L
    J Med Virol; 2006 Oct; 78(10):1262-8. PubMed ID: 16927278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predominance of CCR5-dependent HIV-1 subtype E isolates in Cambodia.
    Menu E; Reynes JM; Müller-Trutwin MC; Guillemot L; Versmisse P; Chiron M; An S; Trouplin V; Charneau P; Fleury H; Barré-Sinoussi F; Sainte Marie FF
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Apr; 20(5):481-7. PubMed ID: 10225231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes.
    Garrido C; Roulet V; Chueca N; Poveda E; Aguilera A; Skrabal K; Zahonero N; Carlos S; García F; Faudon JL; Soriano V; de Mendoza C
    J Clin Microbiol; 2008 Mar; 46(3):887-91. PubMed ID: 18199789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indian primary HIV-2 isolates and relationship between V3 genotype, biological phenotype and coreceptor usage.
    Kulkarni S; Tripathy S; Agnihotri K; Jatkar N; Jadhav S; Umakanth W; Dhande K; Tondare P; Gangakhedkar R; Paranjape R
    Virology; 2005 Jun; 337(1):68-75. PubMed ID: 15914221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of X4/DM-tropic viruses in PBMC samples from patients with primary HIV-1 subtype-B infection in 1996-2007: the French ANRS CO06 PRIMO Cohort Study.
    Frange P; Galimand J; Goujard C; Deveau C; Ghosn J; Rouzioux C; Meyer L; Chaix ML
    J Antimicrob Chemother; 2009 Jul; 64(1):135-41. PubMed ID: 19411680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable coreceptor usage of HIV in patients with ongoing treatment failure on HAART.
    Lehmann C; Däumer M; Boussaad I; Sing T; Beerenwinkel N; Lengauer T; Schmeisser N; Wyen C; Fätkenheuer G; Kaiser R
    J Clin Virol; 2006 Dec; 37(4):300-4. PubMed ID: 17005445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 coreceptor usage determination in clinical isolates using clonal and population-based genotypic and phenotypic assays.
    Van Baelen K; Vandenbroucke I; Rondelez E; Van Eygen V; Vermeiren H; Stuyver LJ
    J Virol Methods; 2007 Dec; 146(1-2):61-73. PubMed ID: 17640743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.